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Effect of Manipulating Intraamygdala Levels 
of cGMP on Fear Conditioning. 
J.W. Landsberg 
Dqjartments of Psychology and Psychiatry, Yale University and the Ribicofif Research Facilities of the 
Connecticut Mental Health Center, New Haven, CT 06508 
Long-term potentiation (LTP) describes the persistent, activity dependent increase 
in synaptic efficacy which has been seen in many vertebrate brain areas both in vitro and in 
vivo and is considered by many to be a promising model of learning and memory. Recent 
in vitro studies of the CAl region of the rat hippocampus have implicated cyclic guanosine 
3’,5’-monophosphate (cGMP) as an important second messenger in the formation of LTP, 
LY-83583, an inhibitor of cGMP production, was shown to block LTP, while addition of 
8 Br-cGMP, the membrane permeable cGMP analogue, produced LTP. We conducted the 
following experiments to investigate the effect of intraamygdala infusion of LY-83583 
and 8 Br- cGMP on fear conditioning, an example of in vivo learning, as measured 
behaviorally by fear potentiated startle in male Sprague - Dawley rats. Bilateral 
intraamygdala infusion of 2.5 nmol LY-83583, 6 min prior to 30 light - shock (0.6mA) 
pairings, failed to block the acquisition of conditioned fear. Bilateral intraamygdala 
infusion of 50nM 8 Br-cGMP, 6 min prior to 30 light -shock pairings, failed to enhance 
the acquisition of either weak fear conditioning or strong fear conditioning. Overall, we 
were not able to manipulate the acquisition of fear potentiated startle by intraamygdala 
infusion of these two agents recently shown to impair and enhance LTP in vitro. 
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Introduction 
Long-term potentiation (LTP) describes the persistent, activity dependent increase 
in synaptic efficacy which has been seen in many vertebrate brain areas both in vitro and in 
vivo (Nicoll et al 1988). Because LTP is considered by many to be a promising model of 
learning and memory, understanding the molecular events involved in LTP and the roles 
played by the presynaptic and postsynaptic neurons is an area of active investigation. 
Currently it is felt that LTP is a two stage phenomenon having both an induction and a 
maintenance phase. 
Induction is believed to be largely a postsynaptic cell phenomenon. It is felt that 
glutamate released by presynaptic neurons binds to two distinct targets on postsynaptic 
neurons, NMDA and non - NMDA receptors. The non - NMDA receptors, upon binding 
glutamate, allow a small inward Na+ current, which produces an excitatory postsynaptic 
potential (EPSP). When glutamate binds to the postsynaptic NMDA receptors one of two 
events occurs. If the postsynaptic cell is at resting membrane potential, the NMDA 
receptor’s ion channel will be blocked by a Mg-H- ion and nothing occurs. However, if the 
postsynaptic cell has been recently depolarized, the Mg++ block wlU be removed and 
binding of glutamate leads to a Ca-H- influx which triggers LTP (Fig. 1). It has been 
shown in vitro that NMDA receptor antagonists, Ca-H- chelating agents, and artificial 
hyperpolarization of postsynaptic neurons aU block LTP. Similarly intracellular micro¬ 
injection of Ca-H- into postsynaptic neurons has been shown to trigger LTP (Nowak et al 
1992). In short, the second messenger in the induction of LTP is believed to be the 
postsynaptic, NMDA receptor mediated, Ca-H- influx. 
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Maintenance of LTP was shown by Bekkers and Stevens (Bekkers et al 1990) to 
be largely a phenomenon of the presynaptic neuron accomplished by an increase in release 
of neurotransmitter. Implicating the presynaptic cell in the maintenance of LTP implied the 
existence of a retrograde signal linking the postsynaptic cell to the presynaptic cell, and 
LTP induction to LTP maintenance. Searching for a possible retrograde messenger, 
Madison and Schuman (1991) demonstrated that NO synthase inhibitors blocked LTP 
when injected directly into postsynaptic neurons. Recently, KandeTs group in a series of 
experiments have impUcated guanylate cyclase and cychc guanosine 3’,5’-monophosphate 
(cGMP) production as the target of the retrograde signal. Their in vitro studies of the CAl 
region of the rat hippocanpus have demonstrated that LY-83583, an inhibitor cGMP 
production, blocked LTP (Zhuo et al 1994). Furthermore, addition of the membrane 
permeable cGMP analogue, 8 Br-cGMP, paired with weak stimulation of presynaptic 
neurons produced LTP (Zhuo et al 1994). As predicted, inhibition of LTP by both NO 
synthesis inhibitors and LY-83583 was over come by administration of 8 Br- cGMP(Zhuo 
et al 1994). These data implicated NO as the retrograde messenger, and cGMP as the 
presynaptic second messenger of LTP maintenance (Fig. 1). 
We have previously demonstrated that NMDA antagonists that block the induction 
of LTP in vitro will similarly block learning, specifically conditioned fear, when infused 
directly into the amygdala (Miserendino et al 1990). We conducted the following 
experiments to investigate the effect of manipulating intraamygdala levels of cGMP on the 
acquisition of conditioned fear in male Sprague - Dawley rats as measured behavioraUy by 
fear potentiated startle. Fear potentiated startle is a paradigm whereby the acoustic startle 
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reflex is inereased when elieited in the presenee of a neutral stimulus (e.g. light) previously 
paired with an aversive stimulus such as shock (Davis & Astrachan, 1978), as illustrated in 
Fig. 6. Under normal circumstances the magnitude of the increase in the startle reflex over 
baseline is related to the strength of the fear conditioning. 
The first experiment examined the effect of intraamygdala infusion of LY-83583, 
an inhibitor of cGMP production, (Brandt et al 1991) on the acquisition of conditioned 
fear as measured by fear potentiated startle. To demonstrate correct cannula placement 
and effective drug delivery animals that previously received LY-83583 were given an 
intraamygdala infusion of NBQX, a glutamate receptor antagonist known to block the 
expression of fear potentiated startle when infused directly into the amygdala (Kim et al 
1993), and re-tested for fear potentiated startle. 
Next we established an intensity response curve for various foot shock intensities 
on the acquisition of conditioned fear to determine a training intensity where only weak 
fear conditioning occurs. Then we examined the effect of intraamygdala infusion of 8 Br- 
cGMP on weak (0.2mA shock) fear conditioning. Finally we investigated the effects of an 
intraamygdala infusion of 8 Br-cGMP on strong (O.drnA shock) fear conditioning. 
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Fig. 1. Schematic diagram depicting the theoretical intracellular and intercellular signals and 
second messengers involved in LTP induction and maintenance. Glutamate released by an excitatory 
presynaptic neuron binds NMDA and non - NMDA receptors on a postsynaptic neuron. The non - NMDA 
receptor allows a small inward Na+ current. If the postsynaptic cell has been recently depolarized, the 
Mg++ block of the channel coupled to the NMDA receptor will be removed and binding of glutamate 
leads to a Ca++ influx which triggers LTP. The postsynaptic Ca++ spike triggers the synthesis and 
release of nitric oxide (NO ) which then diffuses to the presynaptic neuron where it stimulates guanylyl 
cyclase resulting in an increase in the concentration of cGMP, which is required for LTP maintenance. 
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Unconditioned Light 
Fig. 2. Schematic diagram depicting the effect of an unconditioned light stimulus in the amygdala. 
An unconditioned light stimulates the release of glutamate (Glu) in the amygdala by excitatory 
presynaptic neurons receiving visual input. The glutamate binds to both NMDA and non - NMDA 
receptors. The non - NMDA receptors allow a small inward Na+ current which produces an equally small 
excitatory postsynaptic potential (EPSP). The NMDA receptor’s ion channel is blocked by a Mg++ ion 
and nothing occurs. 
Shock 
Fig. 3. Schematic diagram depicting the effect of a shock stimulus in the amygdala. A shock 
stimulates the release of glutamate (Glu) in the amygdala by excitatory presynaptic neurons. The 
glutamate binds to non - NMDA receptors and leads to a Na+ influx, depolarizing cells in the amygdala. 
The NMDA receptor’s Mg++ block is removed 
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Training 
(T.igjit - Shock. Fairing ) 
Fig. 4. Schematic diagram depicting the effect of light - shock pairing in the amygdala. A shock 
stimulates the release of glutamate (Glu) in the amygdala which binds to non - NMDA receptors and leads 
to a Na+ influx, depolarizing cells in the amygdala. The NMDA receptor’s Mg++ block is removed. An 
unconditioned light stimulates the release of glutamate (Glu) in the amygdala which binds to both NMDA 
and non - NMDA receptors. The non - NMDA receptors allow a small inward Na+ current. The NMDA 
receptor allows a Ca++ influx which triggers LTP. 
Conditioned Llglit 
Fig. 5. Schematic diagram depicting the effect of a conditioned light stimulus in the amygdala. A 
conditioned light stimulates the release of glutamate (Glu) in the amygdala which binds to non - NMDA 
receptors and leads to a Na+ influx, depolarizing the cells in the amygdala. After training the visual input 
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TRAINING: Li^t shock pairing 
TESTING: 
Fig. 6. Cartoon depicting the fear-potentiated startle paradigm. During training an unconditioned 
stimulus, shock, is repeatedly paired with a neutral stimulus, light. During testing startle is elicited by an 
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Materials and Methods 
Apparatus 
Fear conditioning and fear potentiated startle testing were conducted in five 
identical stabilimeter devices that have been described previously (Cassella & Davis, 
1986). Briefly, each stabilimeter consisted of an 8 cm X 15 cm X 15 cm Plexiglas and wire 
mesh cage suspended between compression springs within a steel frame. The floor of each 
stabilimeter consisted of four, 6.0-mm diameter stainless steel bars spaced 18 mm apart 
which delivered shock. Cage movement resulted in displacement of an accelerometer with 
the resulting voltage being proportional to the velocity of displacement. The analog output 
of the accelerometer was amphfied and digitized. Startle amplitude was defined as the 
peak accelerometer voltage that occurred during the first 200 ms after the onset of the 
startle stimulus. The stabilimeters were housed in a dimly lit, ventilated, sound attenuating 
chamber. A surveillance camera was positioned behind each stabilimeter to allow 
observation of the animals. Background noise (70 dB) was provided by a white noise 
generator. The light conditioned stimulus was produced by an 8 - W fluorescent bulb 
attached to the back of each stabilimeter. 
Experiment #1. Effect of intraamygdala infusion of LY-83583, an inhibitor of cGMP 
production (Brandt et al 1991), during hght - shock training, on the acquisition of fear 
conditioning as measured by fear potentiated startle. 
Procedure 
Twenty male, albino Sprague - Dawley rats weighing between 350 and 450g were 
anesthetized with Nembutal 50mg/cc, 0.125cc /lOOg body weight, and placed into a 
10 
■wff ai tfvsw 
,kvk<1 j*i txy^h-lr^^b w^sj^i uiillt »ii3iy!jsj6 T54?i>ru31di6rf^ 
■Jim vvi^ mo I -,< mo' li X mo X'n«'to 
a^a-j'to 'toi)}'! iirfT .^fnmf {»oi« b nisiiiv: fmaV.n<iffioo 0mwH<i 'b$tif.r:^^m sgfio ikata 
■"iiific umi ! ,‘rjOiS<|3'VfTf5d ioou se-jini^td rMiiaib mist-O.d /mdl lo lyypimm 
fiiKv toromoioboofs ;;r. ’lo jft-omooiJt^sfb a? tQffl«3»vc'5Y. o;^:> bwdoli 4oitW, 
bqJm? ^<'>ifi”P. s^')T JjTiJi..V'jiftJfjfiib / jiT»olAV oS b;artj|iC'i5<iTq tuff 
‘jfh ii: bofirit't* tiij-v Aiifim .k-p;iii^ki PjctA a^rw Tol!af!ftO’ii49'i^ 3*U 
■MiJ Uj ‘,^ii iof;6 I'm ^>0i: ;Ki7i g3ihi5b'H‘'fWif> xorit o^.)k?v 
t,m-Ki .h'ii&lisA ;v JH ylfulb n fii b^auoH odT Mihmtu 9/hisj« 
woiiii <y uibi'ifirjijji'. fi;-*«:> bftobd JiafiorTf»'i>q i»>sf imujym A viadten^ 
^'■'j'Oii yjTtfUv £i Yt> bAbrvo;(j .it;w (^}j or) yjtfofl MtutBiJis, 3(t|*!o 
<;<A;cf W - 8 m: {<1 «nv bbwajiii^nx) iib^i »dl’ .-JOJtn^®^ 
. ijhrf*!} lo sefil oJ boria^iw 
W»>o'to roMdi^ na .m irt2««s3fVi«jKH 
iurji to ofti (fo ‘A'jode - liJjjti )^^mb,([Wf la io46riiir>a) a<MJ>>^4>oiq 
.3ll7.i^ bn»l|?ilrj;;3)l{j;^ {^ltr£a:9Ul it^iiHGiiihijf/^ 
iTj« ifiit. Imt o?t - aftimqK omdU-.iUm tircwT , «, 
*.«(»l|34,t fe« i4*iBW sMI' baaMiam 
stereotaxic instrument fitted with blunt ear bars. The skull was exposed and two holes 
were drilled above the amygdala at the following coordinates relative to bregma: anterior 
= -2.8; lateral = +/- 5.3. Cannulae (22 gauge outer cannulae, 26 gauge guide stylet) were 
lowered to -8.5 mm and glued to the skull with Loctite adhesive. Four 0-80 jewelers 
screws were placed in the skull, one anterior and one posterior to each cannula, and dental 
cement was then applied over the skull to stabilize and secure the cannulae. Each cannula 
was then covered with a screw on dust cap. One animal died at surgery. Twelve days after 
surgery 18 animals were matched, i.e. exposed to 30 startle alone stimuli consisting of a 
either a 100 dB, 105 dB, 110 dB, 50 ms burst of white noise presented in balanced 
irregular order with a 30 s inter-stimulus interval and divided into two groups having 
similar mean baseline startle amplitudes. One animal was excluded because of an 
aberrantly high baseline startle. One day later eight animals were infused with 2.5 nmol 
LY-83583 in 0.3 pi of PBS bilaterally, and nine animals with PBS alone as a control. The 
infusions occurred over 3 min. Injection cannulae remained in place for 1 min after 
injection. The 26 gauge stylets were then inserted into the cannulae, dust caps were 
replaced, and the animals were then placed into the startle apparatus. Training consisted of 
a 5-min acclimation period, followed by 30 light - shock pairings which consisted of a 
3700 ms light paired with a 500 ms, 0.6mA shock presented 3200 ms after the light onset. 
The inter-trial interval alternated between 45 s, 60 s, and 75 s. Two days later the animals 
were tested for the acquisition of fear potentiated startle. Testing consisted of a 5-min 
acclimation period followed by 30 startle alone stimuli randomly mixed with 30 light - 
startle trials where the startle stimulus was delivered 3200 ms after light onset. Startle 
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stimuli consisted of a either a 100 dB, 105 dB, 110 dB, 50 ms burst of white noise 
presented in balanced irregular order with a 30 s inter-trial interval. 
Experiment #2: Effect of intraamygdala infusion of NBQX on the expression of fear 
potentiated startle, in animals which previously received LY-83583 in experiment #1. 
Procedure 
Six days after their last training session and four days after their last test session, 
the 18 rats used in experiment #1 were briefly retrained for fear potentiated startle. Brief 
training consisted of 10 Ught -shock trials performed as previously described. The next day 
the animals were briefly re-tested for the acquisition of fear potentiated startle receiving 3 
startle alone and 3 Ught startle trials as previously described. The following day the same 
eight animals that previously received LY-83583 were infused with 0.3 pg NBQX in PBS 
bilaterally. The nine control animals again received PBS. All animals were then tested for 
fear potentiated startle as previously described. 
Experiment #3: Effect of various foot shock intensities on the acquisition of conditioned 
fear as measured by fear potentiated startle. 
Procedure 
Twenty male, albino Sprague - Dawley rats weighing between 250 and 350g were 
matched as previously described and divided into four groups having similar mean baseline 
startle ampUtudes. One day after matehing the animals were trained for fear potentiated 
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0.0 rtiA, 0.2 mA, 0.3 mA, or 0.4 mA. Two days after training, the animals were tested for 
fear potentiated startle as previously deseribed. This experiment was then repeated with 20 
new animals and the data eombined. 
Experiment #4: Effect of intraamygdala infusion of 8 Br-cGMP during weak (0.2 mA) 
shock training, on the acquisition of conditioned fear as measured by fear potentiated 
startle. 
Procedure 
Twenty two male, albino Sprague - Dawley rats weighing between 400 and 500g 
were implanted with bilateral amygdala cannulae as previously described. Four animals 
died immediately post-op and four animals lost their cannulae during the postoperative 
recovery period. Twenty days after surgery 14 animals were matched as previously 
described. Four days later seven animals were infused with 50 nM 8 Br-cGMP in ACSF 
bilaterally, and seven animals with ACSF alone as a control. The infusions and training 
were performed as previously described except that shock intensity was 0.2mA. Two days 
later the animals were tested for fear potentiated startle as previously described in 
experiment 1. 
Experiment #5: Effect of intraamygdala infusion of 8 Br-cGMP during strong shock 
(0.6mA) training, on the acquisition of conditioned fear as measured by fear potentiated 
startle. 
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Procedure: 
Two days after their last test session the seven animals that received 8 Br-cGMP in 
experiment #5 again were infused with 50 nM 8 Br-cGMP in ACSF bilaterally. Similarly, 
six of the seven animals who received ACSF alone in experiment #5 were again infused 
with ACSF as a control. One animal was excluded because of an aberrantly high baseline 
startle. Infusions and training occurred as previously described with a shock intensity of 
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Four animals did not receive shock during training because of a mechanical 
problem and were excluded from the data analysis. Fig. 7 shows the mean startle 
amphtude in the remaining animals for startle alone and Ught startle trials in animals 
receiving an intraamygdala infusion of either LY-83583 or phosphate buffered saline 
(PBS) during training. Bilateral intraamygdala infusion of 2.5 nmol LY-83583, 6 min. 
prior to 30 Ught - shock (0.6mA) pairings, had no effect on the acquisition of conditioned 
fear as measured by fear potentiated startle two days later. Animals that had received LY- 
83583 demonstrated a 32% ( ± 6%) increase in startle amphtude during hght-startle trials. 
Similarly animals that had received PBS demonstrated a 31%(± 7%) increase in startle 
amphtude during hght-startle trials. Analysis of variance of these data using trial type 
(Light - Startle vs. Startle alone) as a within-subjects factor and drug exposure (LY-83583 
vs. PBS) as a between-subjects factor revealed a significant effect of trial type (F 1,12 = 
33.820, P <.001 ) indicating fear potentiated startle. However, there was no significant 
drug by trial type interaction (F 1,12 = 0.060, P <0.811) indicating LY-83583 had no effect 
on the acquisition of fear potentiated startle. Subsequent individual t-tests performed on 
the two trial types found significant enhancement of startle by the hght in the PBS group 
(t6 = 4.134, P <0.01) as weU as in the LY-83583 group (te = 4.100, P <0.01). 
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Fig. 7. Test for the acquisition of conditioned fear as measured by fear potentiated startle in 
animals receiving LY-83583 during (0.6niA) light-shock training. Black bars represent the mean 
amplitude of the acoustic startle reflex alone. White bars represent the mean amplitude of the acoustic 
startle reflex when elicited in the presence of a fear conditioned light stimulus. Stripped bars represent the 
mean difference between the startle alone and light-startle trials, defined as fear potentiated startle. Error 
bars represent ± S.E.M. 
Experiment 2 
Fig. 8 shows the mean startle amplitude for startle alone and light startle trials in 
the animals from experiment #1 receiving an intraamygdala infusion of either NBQX or 
PBS prior to re-testing for fear potentiated startle. Bilateral intraamygdala infusion of 0.3 
pg of NBQX, 6 min prior to testing completely blocked the expression of fear potentiated 
startle in animals who previously received LY-83583 in experiment #1, demonstrating 
correct cannulae placement and effective drug delivery. Animals that had received NBQX 
demonstrated no increase, 2%(+8%), in startle ampUtude during light-startle trials. 
Animals that had received PBS demonstrated a 60% (±14%), increase in startle amplitude 
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vs. Startle alone) as a within-subjects factor and drug exposure (NBQX vs. PBS) as a 
between - subjects factor revealed a significant effect of trial type (F 1,14 = 14.220, P 
<.002), indicating fear potentiated startle, as well as a significant drug by trial-type 
interaction (F 1,14 = 14.539, P <0.002), reflecting the differential effect of the hght in the 
PBS vs. NBQX treated animals. Subsequent individual t-tests performed on the two trial 
types found significant enhancement of startle by the light in the PBS group (t8 = 4.529, P 
<0.001) but not in the NBQX group (t6 = 0.063, P <0.475). 
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Fig. 8. Re-test for the expression of fear potentiated startle in animals from experiment #1 receiving 
either NBQX or PBS during re-testing. Black bars rqjresent the mean amplitude of the acoustic startle 
reflex alone. White bars represent the mean amplitude of the acoustic startle reflex when elicited in the 
presence of a fear conditioned light stimulus. Stripped bars represent the mean difference between the 
startle alone and light-startle trials, defined as fear potentiated startle. Error bars represent ± S.E.M. 
Experiment 3 
Fig. 9 shows the mean startle amplitude for startle alone and light startle trials in 
animals receiving either a 0.0mA, 0.2mA, 0.3niA, or 0.4niA shock during training. 
Animals receiving light - shock training at 0.0mA (no shock) demonstrated an average 
9% (±15%) increase in startle amphtude during light-startle trials over baseline startle 
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alone trials. Of the nine animals receiving 0.0mA (no shock), five demonstrated a fear 
potentiated startle of ^10% (±15%) of baseline (Fig.lO). Animals receiving light - shock 
training at 0.2mA intensity demonstrated an average 40% (±16%) increase in startle 
amphtude during hght-startle trials. Five of the nine animals receiving 0.2mA shock, 
demonstrated a fear potentiated startle of ^ 10%(±16%) (Fig.l 1). Animals receiving light 
- shock training at 0.3niA intensity demonstrated an average 46%(±10%) increase in 
startle amphtude during hght-startle trials, and fmaUy animals receiving hght - shock 
training at 0.4mA intensity demonstrated an average 57%(±12%) increase in startle 
amphtude during hght-startle trials. All 18 animals receiving either 0.3mA or 0.4mA shock 
during training demonstrated a fear potentiated startle of >10% (±10 %, ±12% 
respectively) (Fig. 12,13). Therefore 0.2mA, which produced < 10% fear potentiated 
startle in more then 50% of animals, was adopted as an intensity which produced only 
weak fear conditioning. Analysis of variance of these data using trial type (Light - Startle 
vs. Startle alone) as a within-subjects factor and shock intensity (0.0mA, 0.2mA, 0.3niA, 
0.4mA) as a between - subjects factor revealed a significant effect of trial type (F 1,32 = 
47.768, P <.001 ) indicating fear potentiated startle, as weh as a significant shock intensity 
by trial-type interaction (F 1,32 = 3.888, P <0.018), reflecting the differential effect of the 
hght in animals receiving different training shock intensities. Subsequent individual t-tests 
performed on the two trial types found significant enhancement of startle by the hght in ah 
groups receiving shock, 0.2mA (t? = 2.560, P <0.038), 0.3mA (t8 = 6.082, P <0.001), 
0.4mA(t8 = 5.677, P <0.001). 
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Fig. 9. Test for the expression of fear potentiated startle in animals receiving various shock 
intensities during fear conditioning. Black bars represent the mean amplitude of the acoustic startle 
reflex alone. White bars represent the mean amplitude of the acoustic startle reflex when ehcited in the 
presence of a fear conditioned light stimulus. Stripped bars represent the mean difference between the 
startle alone and light-startle trials, defined as fear potentiated startle (fear potentiated startle). Error bars 



















-60 individual animals 
□ 0.0mA 
Fig. 10. % increase in fear potentiated startle over baseline startle in animals receiving 0.0mA, no 
shock, sham fear conditioning. White bars represent the mean % increase in fear potentiated startle over 
baseline. Data displayed by individual animal, n=9. Error bars represent ± S.E.M. 
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Fig. 11. % increase in fear potentiated startle over baseline startle in animals receiving O.lmA 
footshock fear conditioning. White bars represent the mean % increase in fear potentiated startle over 
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□ 0.3mA 
individual animals 
Fig. 12. % increase in fear potentiated startle over baseline startle in animals receiving 0.3mA 
footshock fear conditioning. White bars represent the mean % increase in fear potentiated startle over 
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□ 0,4mA 
Fig. 13. % increase in fear potentiated startle over baseline startle in animals receiving 0.4mA 
footshock fear conditioning. White bars represent the mean % increase in fear potentiated startle over 
baseline. Data displayed by individual animal, n=9. Error bars represent ± S.E.M. 
20 
Tmv jLnm imi ni Mixru^i*. a&m -n^ \,Tu»f 
rOW 
K<«rr<y>« 
* wtJ I 1: i tinfffiT iw» ail Miw^iauj ^ *I| ^ 
-»vf> scrjfc/> imtortT -4)ins (tJi (ri wtopal .>A*i ,,*q ifliswoMsi «»f^uJW wA 4»mkUi^ 
M f? 8 i' Ji/^vi'vt« Wai'»T»3 liwwa^ bis^qiikjlD SjbMJ'sV)4tUMWd 
St 
ul,v}hi»i4 -m^zy.) -^^>1 ■lal^'r*jif» je jFj ,j0 
tm yt‘^ lics*tt4jif,*«<n( lisoi ;n «»»m .Jg^whw^ wA 4m4«MI 
-W.SIK i. Jfoid^iqjwKiial 
I' 
Experiment 4 
Fig. 14 shows the mean startle amplitude for startle alone and light startle trials in 
animals receiving an intraamygdala infusion of either 8 Br-cGMP or artificial cerebral 
spinal fluid (ACSF) prior to weak fear conditioning. Bilateral intraamygdala infusion of 
50nM 8 Br-cGMP, 6 min. prior to 30 light - (0.2mA) shock pairings, had no effect on the 
acquisition of weak fear conditioning as measured by fear potentiated startle two days 
later. Animals that had received 8 Br-cGMP demonstrated a 28% (±12%) increase in 
startle amplitude during light-startle trials. Similarly, animals that had received ACSF 
demonstrated a fear potentiated startle 12% (±8%) of baseline. Three of the six animals 
receiving 8 Br-cGMP, demonstrated a fear potentiated startle of 10%(±8%) of baseline 
(Fig. 16). Five of the six animals receiving ACSF, demonstrated a fear potentiated startle 
of ^ 10%(±12%) of baseline (Fig. 15). Analysis of variance of these data using trial type 
(Light - Startle vs. Startle alone) as a within-subjects factor and drug exposure (8 Br- 
cGMP vs. ACSF) as a between-subjects factor failed to reveal a significant effect of trial 
type (F 1,12 = 0.584, P <.453 ) failing to demonstrate fear potentiated startle. Similarly, 
there was no significant drug by trial type interaction (F 1,20 = 0.078, P <0.782) indicating 
8 Br-cGMP had no effect on the acquisition of fear potentiated startle. Subsequent 
individual t-tests performed on the two trial types again failed to demonstrate significant 
enhancement of startle by the light in either the ACSF group (t5 = 1.3760, P <0.228) or 
the 8 Br-cGMP group (ts = 2.421, P<0.068). 
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■ STARTLE (S) 
□ LIGHT-STARTLE (LS) 




0.2mA Training Shock Intensity 
Fig. 14. Test for the expression of fear potentiated startle in animals receiving either 8 Br-cGMP or 
artiflcial cerebral spinal fluid (ACSF) during weak (0.2mA) fear conditioning. Black bars represent 
the mean amplitude of the acoustic startle reflex alone. White bars represent the mean amplitude of the 
acoustic startle reflex when elicited in the presence of a fear conditioned light stimulus. Stripped bars 
represent the mean difference between the startle alone and light-startle trials, defined as fear potentiated 
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Fig. 15. % increase in fear potentiated startle over baseline startle in animals receiving ACSF 
during weak (0.2mA) fear conditioning. White bars represent the mean % increase in fear potentiated 
startle over baseline. Data displayed by individual animal, n=6. Error bars represent ± S.E.M. 
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Fig. 16. % increase in fear potentiated startle over baseline startle in animals receiving 8 Br-cGMP 
during weak (0.2mA) fear conditioning. White bars represent the mean % increase in fear potentiated 
startle over baseline. Data displayed by individual animal, n=6. Error bars represent i S.E.M. 
Experiment 5 
Fig. 17 shows the mean startle amplitude for the first 60 startle alone and light 
startle trials in animals receiving an intraamygdala infusion of either 8 Br-cGMP or 
artificial cerebral spinal fluid (ACSF) prior to strong fear conditioning. Bilateral 
intraamygdala infusion of 50nM 8 Br-cGMP, 6 min. prior to 60 light - shock (0.6mA) 
pairings, had no effect on the acquisition of strong fear conditioning as measured by fear 
potentiated startle 17 days later. Animals that had received 8 Br-cGMP demonstrated a 
58% (±10%) increase in startle amphtude during Ught-startle trials. Similarly, animals that 
had received ACSF demonstrated a fear potentiated startle 69% (±16%) of baseline. 
Analysis of variance of these data using trial type (Light - Startle vs. Startle alone) as a 
within-subjects factor and drug exposure (LY-83583 vs. PBS) as a between-subjects 
factor revealed a significant effect of trial type (F 1,20 = 5.977, P <.024 ) indicating fear 
potentiated startle. However, there was no significant drug by trial type interaction (F 1,20 
= 0.001, P <0.977) indicating 8 Br-cGMP had no effect on the acquisition of fear 
potentiated startle. Subsequent individual t-tests performed on the two trial types found 
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significant enhancement of startle by the light in the ACSF group (ts = 3.550, P <0.02) as 
well as in the 8 Br-cGMP group (t6 =9.700, P <0.001). 
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Fig. 17. Test for the expression of fear potentiated startle in animals receiving either 8 Br-cGMP or 
artificial cerebral spinal fluid (ACSF) during strong (0.6niA) fear conditioning. Black bars represent 
the mean amplitude of the acoustic startle reflex alone. White bars represent the mean amplitude of the 
acoustic startle reflex when elicited in the presence of a fear conditioned light stimulus. Stripped bars 
represent the mean difference between the startle alone and Ught-startle trials, defined as fear potentiated 
startle. The 7 animals receiving 8 Br-cGMP, and the six controls, are the same animals that received 8 Br- 
cGMP and ACSF respectively in experiment #4. Error bars represent ± S.E.M. 
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Discussion 
Recent studies have implicated cGMP as a crucial second messenger involved in 
LTP. Because LTP may ultimately involve an increase in presynaptic transmitter release, 
various retrograde messengers have been proposed to explain how events in the post- 
synaptic cell can affect the presynaptic cell. In addition to NO (see introduction), other 
putative retrograde messengers such as carbon monoxide and arachidonic acid (Williams 
et al 1989) are known to be coupled to cGMP. Hence treatments that alter cGMP would 
be expected to alter LTP, regardless of the retrograde messenger, which may vary from 
brain area to brain area. Addition of 8 Br-cGMP paired with weak presynaptic stimulation 
has been shown to induce LTP in at least two distinct in vitro models (Bennett et al 1993; 
Hawkins et al 1994). Similarly, inhibitors of cGMP such as LY-83583 have been shown to 
inhibit LTP (Zhuo et al 1994). The present experiments were conducted in an attempt to 
demonstrate the role of cGMP in a behavioral model of learning, namely fear 
conditioning. Fear conditioning was measured via the fear potentiated startle paradigm, 
where the strength of learning is related to the amplitude of the acoustic startle reflex 
when elicited in the presence of a fear conditioned light stimulus. 
Bilateral intraamygdala infusion of 2.5 nmol LY-83583, prior to light - shock 
(0.6mA) pairing, had no effect on fear conditioning, as measured by the fear potentiated 
startle paradigm. The subsequent infusion of NBQX and re-test for the expression of fear 
potentiated startle demonstrated correct cannulae placement and effective drug delivery in 
animals previously infused with LY-83583. 
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Next we attempted to enhance fear conditioning. In vitro studies of both the rat 
hippocampus and the chick cihary ganglion have demonstrated an increase in LTP after 
the administration of 8 Br-cGMP, when paired with weak presynaptic stimulation (Lin et 
al 1994; Hawkins et al 1994).We generated an intensity response curve to determine a 
shock intensity which produced only weak fear conditioning, reasoning that a weak shock 
would be equivalent to the weak presynaptic stimulation used in the in vitro models. 
As anticipated, the magnitude of fear conditioning increased with increasing shock 
intensity. The mean fear potentiated startle amphtude for the 0.2mA, 0.3mA, and 0.4mA 
groups aU had overlap with respect to SEM, yet examination of the data by individual 
animal revealed dilferences among the groups. 100% of animals receiving either 0.3mA or 
0.4mA shock demonstrated a fear potentiated startle >10% of baseline, where as only 
33% of animals receiving 0.2mA shock, demonstrated a fear potentiated startle of > 10% 
of baseline. Therefore 0.2mA was adopted as an intensity which produced only weak fear 
conditioning. 
Bilateral intraamygdala inftision of 0.3 p.1 50nM 8 Br-cGMP, prior to light - 
(0.2mA) shock pairings, had no effect on the acquisition of weak fear conditioning. When 
examined by individual animal the group receiving 8 Br-cGMP, was similar to both the 
ACSF controls and the 0.2mA shock alone group from experiment #3, suggesting 8 Br- 
cGMP had no effect. We chose 0.2mA because we felt it was a threshold intensity and 
thus would be a sensitive place to look for learning enhancement. Our failure to 
demonstrate significant fear potentiated startle in either the ACSF or the 8 Br-cGMP 
group may suggest that the intraamygdala infusion produced some degree of pressure 
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damage effectively raising this threshold. In hght of this, 0.3mA may have been a more 
appropriate intensity. 
Finally we attempted to enhance strong fear conditioning. Bilateral intraamygdala 
mflision of 0.3 pi 50nM 8 Br-cGMP, prior to light - shock (0.6mA) pairings, had no 
effect on the acquisition of strong fear conditioning as measured by mean fear potentiated 
startle amphtude. 
Overall, we were not able to manipulate the acquisition of fear potentiated startle 
by intraamygdala infusion of agents shown to both impair and enhance in vitro LTP. One 
possibility is that LY-83583 was not effective in blocking cGMP in the amygdala. This 
compound has been shown to work in some tissues and not in others, and has had 
significantly better efficacy in vitro then in vivo (Bandt et al 1991). Other options were to 
attempt to inhibit the cascade upstream with NO synthase inhibitors or NO scavengers, or 
downstream with cGMP dependent protein kinase inhibitors. Recently, NO synthase 
inhibitors which successfully blocked LTP in vitro failed to do so in vivo (Bannerman et al 
1994). Furthermore, prior work in this laboratory found NO synthase inhibitors to be toxic 
when infused directly into the amygdala. NO scavengers such as hemoglobin have a very 
high molecular weight and are difficult to work with in our model. A significant difficulty 
when moving from in vitro to in vivo work is determination of drug dose. To adequately 
rule out the in vivo efficacy of these agents one would have to repeat these experiments at 
other drug concentrations. In addition, measuring intraamygdala levels of cGMP was 
beyond the scope of this research. To definitively imphcate the role cGMP in fear 
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